NEW YORK and LONDON, March 10 /PRNewswire/ -- Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on meeting the challenges of measuring ROI within the changing dynamics of the pharma industry.
*(LOGO 72dpi: Send2Press.com/mediaboom/07-0924-Eularis_72dpi.jpg)
On Wednesday 26 March 2008, Dr. Bates will deliver a presentation titled, "Are You Up to the Challenge of Measuring ROI in Changing Dynamics of the Pharma Industry?" Bates will challenge the thinking of conference attendees and will expose where ROI goes wrong when used to guide current marketing decisions in a changing dynamic market such as pharma. She will also uncover what opportunities are available in this environment, and what can and should be measured for real results when the environment is dynamic.
Bates has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis. Under Bates' leadership, Eularis issued three related research reports in the past year, including: Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line (http://www.pharmamarketingroi.com), Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things? (http://www.pharmaindustrysfe.com), and Ensuring Profitable Patient Adherence Programs by Effectively Using Analytics to Release the Hidden Value Available to the Bottom Line from Adherence (http://www.patientadherenceroi.com).
The conference will be focused on answering three pivotal areas: "Addressing the Challenges in Measuring ROI," "Ensuring the Sales and Marketing Functions are Aligned" and "Leveraging Your Brand Potential."
To arrange an interview with Eularis http://www.eularis.com, please contact Tracey Haefele at +1 646 673 8408 or via email THaefele@Eularis.com.
Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance. Eularis offers pre-launch analytics, marketing mix modeling, portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions. Eularis has developed significant experience in the global pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others.
For more information about Eularis, visit http://www.eularis.com.
This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com
Copyright©2008 PR Newswire.
All rights reserved